Fresenius SE & Co KGaA (FRE) Given a €85.00 Price Target at Deutsche Bank

Deutsche Bank set a €85.00 ($98.84) price target on Fresenius SE & Co KGaA (FRA:FRE) in a research report sent to investors on Thursday morning. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also issued reports on FRE. UBS Group set a €59.00 ($68.60) target price on shares of Fresenius SE & Co KGaA and gave the company a sell rating in a research note on Tuesday, June 26th. Sanford C. Bernstein set a €83.00 ($96.51) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, July 3rd. Morgan Stanley set a €77.00 ($89.53) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, July 3rd. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Friday, July 6th. Finally, Bank of America set a €75.00 ($87.21) target price on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research note on Tuesday, July 10th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has an average rating of Buy and an average target price of €76.44 ($88.89).

Shares of FRA:FRE traded down €0.68 ($0.79) during trading on Thursday, reaching €59.84 ($69.58). 2,362,291 shares of the company traded hands. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Further Reading: What strategies should day traders use to execute a trade?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply